We serve Chemical Name:4-(3-nitrophenyl)benzenesulfonyl chloride CAS:101366-50-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(3-nitrophenyl)benzenesulfonyl chloride
CAS.NO:101366-50-1
Synonyms:3′-nitro-biphenyl-4-sulfonyl chloride
Molecular Formula:C12H8ClNO4S
Molecular Weight:297.71400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:88.34000
Exact Mass:296.98600
LogP:4.79330
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3′-nitro-biphenyl-4-sulfonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3′-nitro-biphenyl-4-sulfonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3′-nitro-biphenyl-4-sulfonyl chloride Use and application,3′-nitro-biphenyl-4-sulfonyl chloride technical grade,usp/ep/jp grade.
Related News: The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. 4-(3-nitrophenyl)benzenesulfonyl chloride manufacturer After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. 4-(3-nitrophenyl)benzenesulfonyl chloride supplier After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. 4-(3-nitrophenyl)benzenesulfonyl chloride vendor The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. 4-(3-nitrophenyl)benzenesulfonyl chloride factory CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.
